Working… Menu

Dose-escalation Study of Lupartumab Amadotin (BAY1129980)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02134197
Recruitment Status : Terminated
First Posted : May 9, 2014
Last Update Posted : December 11, 2019
Information provided by (Responsible Party):